Lab-on-Chip-Based Platform for Fast Molecular Diagnosis of Multidrug-Resistant Tuberculosis
File(s)zjm3876.pdf (134.91 KB)
Published version
Author(s)
Type
Journal Article
Abstract
We evaluated the performance of the molecular lab-on-chip-based VerePLEX Biosystem for detection of multidrug-resistant
tuberculosis (MDR-TB), obtaining a diagnostic accuracy of more than 97.8% compared to sequencing and MTBDRplus assay for
Mycobacterium tuberculosis complex and rifampin and isoniazid resistance detection on clinical isolates and smear-positive
specimens. The speed, user-friendly interface, and versatility make it suitable for routine laboratory use.
tuberculosis (MDR-TB), obtaining a diagnostic accuracy of more than 97.8% compared to sequencing and MTBDRplus assay for
Mycobacterium tuberculosis complex and rifampin and isoniazid resistance detection on clinical isolates and smear-positive
specimens. The speed, user-friendly interface, and versatility make it suitable for routine laboratory use.
Date Issued
2015-12-01
Date Acceptance
2015-07-30
Citation
Journal of Clinical Microbiology, 2015, 53 (12), pp.3876-3880
ISSN
0095-1137
Publisher
American Society for Microbiology
Start Page
3876
End Page
3880
Journal / Book Title
Journal of Clinical Microbiology
Volume
53
Issue
12
Copyright Statement
Copyright © 2015, American Society for Microbiology. All Rights Reserved. This article is freely available at https://dx.doi.org/10.1128/JCM.01824-15.
Subjects
Science & Technology
Life Sciences & Biomedicine
Microbiology
DENSITY DNA ARRAY
MYCOBACTERIUM-TUBERCULOSIS
DRUG-RESISTANCE
RAPID DETECTION
XPERT MTB/RIF
ASSAY
IDENTIFICATION
GENE
Publication Status
Published